Sort   by:  
 Page size 
UnknownFirst nosocomial outbreak of vancomycin-resistant Enterococcus faecium expressing a VanD-like phenotype associated with a vanA genotype.
Not available
S-EPMC1233916 | biostudies-literature
TranscriptomicsTranscriptomic analyses of renal allograft biopsies reveal conserved rejection signatures and molecular pathways
Transcriptomic analyses of renal allograft biopsies reveal conserved rejection signatures and molecular pathways. GEO SuperSeries. This dataset is part of the TransQST collection.
ORGANISM(S): Homo sapiens 
2009-02-24 | E-GEOD-9493 | biostudies-arrayexpress
UnknownTen-year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4-weekly or 8-weekly.
Not available
S-EPMC5724691 | biostudies-literature
UnknownSYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production.
Not available
S-EPMC5928208 | biostudies-literature
UnknownA Randomized Prospective Study Comparing Anti-T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant Patients.
Not available
S-EPMC7403559 | biostudies-literature
UnknownLong-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study.
Not available
S-EPMC5516151 | biostudies-literature
UnknownUsefulness of morphometric image analysis with Sirius Red to assess interstitial fibrosis after renal transplantation from uncontrolled circulatory death donors.
Not available
S-EPMC7181605 | biostudies-literature
UnknownPopulation Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study.
Not available
S-EPMC7691413 | biostudies-literature
UnknownmTOR Inhibition Impairs the Activation and Function of Belatacept-Resistant CD4+CD57+ T Cells In Vivo and In Vitro.
Not available
S-EPMC10142381 | biostudies-literature
UnknownOptimization of de novo belatacept-based immunosuppression administered to renal transplant recipients.
Not available
S-EPMC8246831 | biostudies-literature
Sort   by:  
 Page size